Nicolas Ferreira

viTToria Biotherapeutics, Inc. is a gene-edited cell therapeutics company based in Philadelphia, PA. The company is developing novel CAR-T cell therapies using their proprietary Senza5 platform, which maximizes stemness, durability, and target cell cytotoxicity. The technology is exclusively licensed from the University of Pennsylvania and has pipeline applications in oncology and autoimmune diseases. The company was founded by Bruce A. Peacock and Nicholas Siciliano, with Nicholas Siciliano serving as CEO since incorporation.

Build Momentum, Inc. was founded in 2005 and is a company that helps organizations design, develop, and deploy innovative cleantech projects. The company is based in Sacramento, CA and has subsidiaries in the United States. The company's vision is to create a world where clean energy, water, and transportation are abundant, affordable, and available to all. The company has a team of experts who can take on any aspect of a cleantech project, from developing a blueprint to commercialization.

Keclon SA engages in the development and generation of synthetic enzymes. Its technology platform allows to rapidly generating new and improved enzymes that can significantly reduce production costs using genetic engineering, synthetic biology and directed evolution tools. The company was founded by Hugo Menzella, Leandro Vetcher, Sebastian Bernales and Salvador Peiru, Rodolfo Cabrera in December 2011, and is headquartered in Rosario, Argentina.

Miroculus, Inc. operates as a biotechnology company specializing in microRNA-based diagnostics. It offers a non-invasive microRNA detection platform for molecular data gathering, analysis, and interpretation applications. The company was founded by Alejandro Tocigl Domeyko, Jorge Soto and Fay Christodoulou and is headquartered in San Francisco, CA.

Humboldt Capital LLC (Humboldt Capital) is a venture capital firm founded in 2020. The firm is headquartered in New York.